← Back
Data updated: Mar 10, 2026
MUTUAL PHARM
CardiovascularInfectious Disease
MUTUAL PHARM is a generic drug manufacturer focused on Cardiovascular, Infectious Disease.
1972
Since
24
Drugs
-
Trials
623
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
DOXYCYCLINE HYCLATE 2026-02-19
METRONIDAZOLE 2026-02-17
Labeling
METRONIDAZOLE 2026-02-17
Labeling
METRONIDAZOLE 2026-02-13
SULFAMETHOXAZOLE AND TRIMETHOPRIM 2026-02-10
Labeling
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
DOXYCYCLINE HYCLATE 2026-01-26
Labeling
DOXYCYCLINE HYCLATE 2026-01-20
Labeling
DOXYCYCLINE HYCLATE 2026-01-20
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 50%
1 drugs
Infectious Disease 50%
1 drugs
Pipeline Strength Pro
Loading...
Active (2)
Discontinued (22)
METRONIDAZOLE SULFAMETHOXAZOLE AND TRIMETHOPRIM OXYCODONE AND ACETAMINOPHEN AMITRIPTYLINE HYDROCHLORIDE HYDROCODONE BITARTRATE AND ACETAMINOPHEN LORAZEPAM ACETAMINOPHEN AND CODEINE PHOSPHATE HYDROXYZINE HYDROCHLORIDE DIPHENHYDRAMINE HYDROCHLORIDE ALLOPURINOL PREDNISONE METOCLOPRAMIDE HYDROCHLORIDE SPIRONOLACTONE HYDRALAZINE HYDROCHLORIDE INDOMETHACIN SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH THIORIDAZINE HYDROCHLORIDE SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE CHLORTHALIDONE PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN PROPOXYPHENE HYDROCHLORIDE ERGOLOID MESYLATES
Company Info
- First Approval
- 1972-11-14
- Latest
- 2016-05-09
- Applications
- 58